Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

AKT Inhibitor MK-2206 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

National Cancer Institute (NCI) · 2010
ClinicalTrials.gov · Datasets · License: Public Domain · 2010
Open Source ↗
adult acute megakaryoblastic leukemia (m7), adult acute minimally differentiated myeloid leukemia (m0), adult acute monoblastic leukemia (m5a), adult acute monocytic leukemia (m5b), adult acute myeloblastic leukemia with maturation (m2), adult acute myeloblastic leukemia without maturation (m1), adult acute myeloid leukemia with 11q23 (mll) abnormalities, adult acute myeloid leukemia with del(5q), adult acute myeloid leukemia with inv(16)(p13;q22), adult acute myeloid leukemia with t(16;16)(p13;q22), adult acute myeloid leukemia with t(8;21)(q22;q22), adult acute myelomonocytic leukemia (m4)
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 876387
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.